Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LaLiMo: Lamotrigine vs Levetiracetam in Initial Epilepsy Monotherapy
NCT00242606Phase 3Completed
- Sponsor
- Philipps-Universität Marburg
- Start
- Mar 2005
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of levetiracetam in epilepsy (2 arms), sponsored by Philipps-Universität Marburg. Primary endpoint: Rate of seizure-free patients in the first 6 weeks. Started Mar 2005; status: completed.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00242606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00242606.